My account:




  remember me

Enter   Register
Information
All rights reserved. Any reprinting of materials of the site is possible only with the written permission of administration and with a direct hyperlink to this site.

(#1 2018)



Ãîä:   2019   |   2018   |   2017   |   2016   |   2015   |   2014   |   2013   |   2012   |   2011   |   2010

Íîìåð:   4    |    3    |    2    |    1

METHODOLOGY

Approaches to the Creation of a Unified Method of Calculation of Incremental Cost-Effectiveness Ratio for the Re-Consideration of Lists of Medical Drugs; an Example of Antineoplastic Drugs

V. V. Omelyanovsky2, 3, M. V. Avxentyeva1, 3, M. V. Sura1, 2, G. R. Khachatryan2, 3, A. G. Savilova

1. Center of Expertize and Quality Control of Medical Care, Ministry of Health of the Russian Federation, Moscow, Russia 
2. Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia 
3. Research Financial Institute of the Ministry of Finance of the Russian Federation, Moscow, Russia

For citations: Omelyanovsky V. V., Avxentyeva M. V., M. V. Sura M. V., Khachatryan G. R., Savilova A. G. Approaches to the Creation of a Unifi ed Method of Calculation of Incremental Cost-Effectiveness Ratio for the Re-Consideration of Lists of Medical Drugs; an Example of Antineoplastic Drugs. Medical Technologies. Assessment and Choice. 2018; 1(31): 10–20.
Real-World Data Studies: from Data to Health Technology Assessment and Decision-Making in Healthcare

T. A. Goldina, N. I. Suvorov 

Takeda Pharmaceuticals, LLC, Moscow, Russia

For citations: Goldina T. A., Suvorov N. I. Real-World Data Studies: from Data to Health Technology Assessment and Decision-Making in Healthcare. Medical Technologies. Assessment and Choice. 2018; 1(31): 21–29.
INTERNATIONAL EXPERIENCE

Drug Supply and Health Technology Assessment in Canada’s Health Care System

V. A. Lemeshko, T. S. Teptsova 

Center of Expertize and Quality Control of Medical Care, Ministry of Health of the Russian Federation, Moscow, Russia 
I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia

For citations: Lemeshko V. A., Teptsova T. S. Drug Supply and Health Technology Assessment in Canada’s Health Care System. Medical Technologies. Assessment and Choice. 2018; 1(31): 30–39.
MANAGEMENT IN HEALTH CARE

Using the Results of Expert Activities in Assessing the Quality of Resource Management in a Medical Organization

S. S. Budarin, E. V. Smirnova 

Scientific research institute of healthcare organization and medical management the Department of health of Moscow city, Moscow, Russia

For citations: Budarin S. S., Smirnova E. V. Using the Results of Expert Activities in Assessing the Quality of Resource Management in a Medical Organization. Medical Technologies. Assessment and Choice. 2018; 1(31): 40–47.
Organization of Medical Care for Patients with Infections of the Maxillofacial Area in the Moscow Region

A. M. Sipkin, I. A. Davydov, D. V. Akhtyamov, O. Ye. Blagikh 

M. F. Vladimirsky Moscow Regional Research Clinical Institute (MONIKI), Moscow, Russia

For citations: Sipkin A. M., Davydov I. A., Akhtyamov D. V., Blagikh O. Ye. Organization of Medical Care for Patients with Infections of the Maxillofacial Area in the Moscow Region. Medical Technologies. Assessment and Choice. 2018; 1(31): 48–51.
ORIGINAL RESEARCH

Pharmacoeconomic Analysis of Ixazomib Combined with Lenalidomide and Dexamethasone in Adult Patients with Relapsed or Refractory Multiple Myeloma

E. A. Pyadushkina, T. V. Boyarskaya 

Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia

For citations: Pyadushkina E. A., Boyarskaya T. V. Pharmacoeconomic Analysis of Ixazomib Combined with Lenalidomide and Dexamethasone in Adult Patients with Relapsed or Refractory Multiple Myeloma. Medical Technologies. Assessment and Choice. 2018; 1(31): 52–67.
Pharmacoeconomic Analysis of Afatinib and Gefitinib for the Treatment of Lung Cancer

D. V. Fedyayev1, 2, S. K. Zyryanov3, 4 

1. Financial Research Institute of the Ministry of Finance of the Russian Federation, Moscow, Russia 
2. Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia 3 RUDN University, Moscow, Russia 4 City Clinical Hospital no. 24, Moscow, Russia

For citations: Fedyayev D. V., Zyryanov S. K. Pharmacoeconomic Analysis of Afatinib and Gefi tinib for the Treatment of Lung Cancer. Medical Technologies. Assessment and Choice. 2018; 1(31): 68–84.
Economic Evaluation of Lenvatinib in Combination with Everolimus for Disseminated Renal-Cell Carcinoma in Russian Federation

Ye. V. Derkach1 , S. Yu. Abashin
1. Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia 
2. The Federal Network of Nuclear Medicine Centers ‘PET-Technology’, Moscow, Russia

For citations: Derkach Ye. V., Abashin S.Yu. Economic Evaluation of Lenvatinib in Combination with Everolimus for Disseminated Renal-Cell Carcinoma in Russian Federation. Medical Technologies. Assessment and Choice. 2018; 1(31): 85–94.
BIOTECHNOLOGIES

Influence of Biological Factors on Transdermal Drug Delivery System

V. V. Tarasov, S. S. Sologova, N. Z. Musina, V. N. Chubarev, S. A. Schakhmardanova, E. M. Grigorevskikh, T. A. Zatsepilova, N. G. Preferanskay, D. I. Sologova 

I. M. Sechenov First Moscow State Medical University, Moscow, Russia

For citations: Tarasov V. V., Sologova S. S., Musina N. Z., Chubarev V. N., Schakhmardanova S. A., Grigorevskikh E. M., Preferanskay N. G., Zatsepilova T .A., Sologova D. I. Infl uence of Biological Factors on Transdermal Drug Delivery System. Medical Technologies. Assessment and Choice. 2018; 1(31): 95–101.
LETTER TO EDITOR

Resolution of the Expert Panel on the Availability of Innovative Treatment of Patients with Atopic Uncontrolled Asthma
© 2019 Health Technology Assessment in Russia. Send a message         |